Inventor
COHEN STANLEY N
US39 patents
⚠️ This page may combine multiple inventors who share the name “COHEN STANLEY N”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV LELAND STANFORD JUNIOR
21 patentsUS4237224ADec 2, 1980
Process for producing biologically functional molecular chimeras
UNIV LELAND STANFORD JUNIOR507 citations97
US5679523AOct 21, 1997
Method for concurrent disruption of expression of multiple alleles of mammalian genes
UNIV LELAND STANFORD JUNIOR78 citations96
US4440853AApr 3, 1984
Microbiological methods using hollow fiber membrane reactor
UNIV LELAND STANFORD JUNIOR71 citations96
US4468464AAug 28, 1984
Biologically functional molecular chimeras
UNIV LELAND STANFORD JUNIOR142 citations95
US6835816B2Dec 28, 2004
Mammalian tumor susceptibility genes and their uses
UNIV LELAND STANFORD JUNIOR21 citations92
US6248523B1Jun 19, 2001
Mammalian tumor susceptibility genes and their uses
UNIV LELAND STANFORD JUNIOR19 citations92
US5891668AApr 6, 1999
Mammalian tumor susceptibility genes and their uses
UNIV LELAND STANFORD JUNIOR22 citations92
US5807995ASep 15, 1998
Mammalian tumor susceptibility genes and their uses
UNIV LELAND STANFORD JUNIOR19 citations92
US4374927AFeb 22, 1983
Extrachromosomal regulation of expression
UNIV LELAND STANFORD JUNIOR30 citations92
US4740470AApr 26, 1988
Biologically functional molecular chimeras
UNIV LELAND STANFORD JUNIOR32 citations91
US4495280AJan 22, 1985
Cloned high signal strength promoters
UNIV LELAND STANFORD JUNIOR35 citations87
US7714108B2May 11, 2010
Mammalian tumor susceptibility gene products and their uses
UNIV LELAND STANFORD JUNIOR4 citations63
US10882821B1Jan 5, 2021
Enantiomeric compound for the reduction of the deleterious activity of extended nucleotide repeat containing genes
UNIV LELAND STANFORD JUNIOR1 citations62
US7838252B2Nov 23, 2010
Methods and compositions for treating a subject having an anthrax toxin mediated condition
UNIV LELAND STANFORD JUNIOR3 citations60
US7592154B2Sep 22, 2009
Modulating SOS response induction by antimicrobial agents
UNIV LELAND STANFORD JUNIOR2 citations56
US5607842AMar 4, 1997
Use of tRNA genes to stabilize the inheritance of unstable plasmids in populations of growing cells
UNIV LELAND STANFORD JUNIOR3 citations54
US7973130B2Jul 5, 2011
Mammalian tumor susceptibility genes and their uses
UNIV LELAND STANFORD JUNIOR0 citations52
US10760077B2Sep 1, 2020
Selective reduction of the deleterious activity of extended tri-nucleotide repeat containing genes
UNIV LELAND STANFORD JUNIOR0 citations50
US9862947B2Jan 9, 2018
Selective reduction of the deleterious activity of extended tri-nucleotide repeat containing genes
UNIV LELAND STANFORD JUNIOR0 citations50
US5422275AJun 6, 1995
Protein production at synthetic start site
UNIV LELAND STANFORD JUNIOR0 citations48
US10675293B2Jun 9, 2020
Nucleoside agents for the reduction of the deleterious activity of extended nucleotide repeat containing genes
UNIV LELAND STANFORD JUNIOR0 citations46
HARVARD COLLEGE
6 patentsUS9816080B2Nov 14, 2017
Delivery of CAS9 via ARRDC1-mediated microvesicles (ARMMs)
HARVARD COLLEGE18 citations92
US11001817B2May 11, 2021
Delivery of cargo proteins via ARRDC1-mediated microvesicles (ARMMs)
HARVARD COLLEGE7 citations83
US10260055B2Apr 16, 2019
Delivery of cargo proteins via ARRDC1-mediated microvesicles (ARMMs)
HARVARD COLLEGE9 citations83
US10945954B2Mar 16, 2021
ARRDC1-mediated microvesicles (ARMMS) and uses thereof
HARVARD COLLEGE7 citations81
US9737480B2Aug 22, 2017
ARRDC1-mediated microvesicles (ARMMs) and uses thereof
HARVARD COLLEGE15 citations81
US11827910B2Nov 28, 2023
Delivery of CAS9 via ARRDC1-mediated microvesicles (ARMMs)
HARVARD COLLEGE1 citations72
CETUS CORP
3 patentsUS4293652AOct 6, 1981
Method for synthesizing DNA sequentially
CETUS CORP118 citations96
US4623627ANov 18, 1986
Monoclonal antibody having specificity for the double-stranded conformation of native DNA and diagnostic methods using same
CETUS CORP35 citations93
US4732852AMar 22, 1988
Site directed peptidase cleavage
CETUS CORP22 citations79
CHENG TZU-HAO
3 patentsUS9211303B2Dec 15, 2015
Selective reduction of the deleterious activity of extended tri-nucleotide repeat containing genes
CHENG TZU-HAO4 citations80
US9226935B2Jan 5, 2016
Methods for modulating the expression and aggregation of a CAG-expanded gene product in cells and methods for identifying agents useful for doing the same
CHENG TZU-HAO4 citations77
US8569254B2Oct 29, 2013
Methods for modulating the expression and aggregation of CAG-expanded gene product in cells and methods for identifying agents useful for doing the same
CHENG TZU-HAO4 citations70